Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiya Horimoto

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Cytokine|May 26, 2012
The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinomaLauren Ewington, Alexandra Taylor, Ruethairat Sriraksa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2026
Clinicopathological predictors of distant recurrence in breast cancer patients achieving pathological complete response after neoadjuvant chemotherapyAsako Yamamoto, Mariko Asaoka, Yoshiya Horimoto, et al.
Japanese Journal of Clinical Oncology|January 22, 2024
Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgeryToshitaka Uomori, Yoshiya Horimoto, Yuko Ueki, et al.
Breast (Edinburgh, Scotland)|December 7, 2020
Clinicopathological features of breast cancer without mammographic findings suggesting malignancyMei Nakamura, Yumiko Ishizuka, Yoshiya Horimoto, et al.
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
Breast (Edinburgh, Scotland)|April 8, 2026
Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer RegistryYoshiya Horimoto, Hiraku Kumamaru, Kyoko Orimoto, et al.
Surgical Case Reports|May 1, 2020
Primary breast non-Hodgkin's lymphoma in a 14-year-old girl: a case reportYumiko Ishizuka, Yoshiya Horimoto, Junya Fujimura, et al.
Anticancer Research|September 30, 2024
CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast CancerNatsuki Uenaka, Eiichi Sato, Yoshiya Horimoto, et al.
Surgical Case Reports|December 12, 2025
Occult Breast Cancer Diagnosed from a Solitary Scalp Metastasis without Axillary Lymph Node Involvement: A Case ReportTomoka Ushio, Saeko Teraoka, Yoshiya Horimoto, et al.
Molecular Cancer|September 5, 2015
Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitroSei Sai, Guillaume Vares, Eun Ho Kim, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Cytokine|May 26, 2012
The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinomaLauren Ewington, Alexandra Taylor, Ruethairat Sriraksa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2026
Clinicopathological predictors of distant recurrence in breast cancer patients achieving pathological complete response after neoadjuvant chemotherapyAsako Yamamoto, Mariko Asaoka, Yoshiya Horimoto, et al.
Japanese Journal of Clinical Oncology|January 22, 2024
Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgeryToshitaka Uomori, Yoshiya Horimoto, Yuko Ueki, et al.
Breast (Edinburgh, Scotland)|December 7, 2020
Clinicopathological features of breast cancer without mammographic findings suggesting malignancyMei Nakamura, Yumiko Ishizuka, Yoshiya Horimoto, et al.
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
Breast (Edinburgh, Scotland)|April 8, 2026
Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer RegistryYoshiya Horimoto, Hiraku Kumamaru, Kyoko Orimoto, et al.
Surgical Case Reports|May 1, 2020
Primary breast non-Hodgkin's lymphoma in a 14-year-old girl: a case reportYumiko Ishizuka, Yoshiya Horimoto, Junya Fujimura, et al.
Anticancer Research|September 30, 2024
CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast CancerNatsuki Uenaka, Eiichi Sato, Yoshiya Horimoto, et al.
Surgical Case Reports|December 12, 2025
Occult Breast Cancer Diagnosed from a Solitary Scalp Metastasis without Axillary Lymph Node Involvement: A Case ReportTomoka Ushio, Saeko Teraoka, Yoshiya Horimoto, et al.
Molecular Cancer|September 5, 2015
Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitroSei Sai, Guillaume Vares, Eun Ho Kim, et al.
Pageof 13